Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v13-EN Version v9-EN
Language English English
Date Updated 2019-05-09 2019-04-30
Drug Identification Number 02172712 02172712
Brand name MYLAN-BECLO AQ MYLAN-BECLO AQ
Common or Proper name BECLO AQ BECLO AQ
Company Name MYLAN PHARMACEUTICALS ULC MYLAN PHARMACEUTICALS ULC
Ingredients BECLOMETHASONE DIPROPIONATE BECLOMETHASONE DIPROPIONATE
Strength(s) 50MCG 50MCG
Dosage form(s) METERED-DOSE AEROSOL SUSPENSION METERED-DOSE AEROSOL SUSPENSION
Route of administration NASAL NASAL
Packaging size 22s 22s
ATC code R01AD R01AD
ATC description DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date 2019-05-08 2019-05-09
Actual start date
Estimated end date Unknown Unknown
Actual end date
Shortage status Actual shortage Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments